Cardioprotection induced by Na+/K+-ATPase activation involves extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt pathway
Authors:
Open Access
- 19 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 89 (1) , 51-59
Abstract
Na+/K+-ATPase (NKA) has recently been found to relay extracellular signals to intracellular compartments. Activation of NKA with polyclonal antibody produces positive inotropic effects. The present study was designed to examine whether DRRSAb, a NKA DR region-specific antibody, also produces cardioprotective effects. Contractile function was examined in both isolated cardiomyocytes and hearts subjected to ischaemic injury. We found that DRRSAb (0.125–2.0 µM) concentration-dependently stimulated the activity of NKA in rat or mouse kidney tissues. Moreover, DRRSAb increased the amplitudes of cell shortening and electrically induced [Ca2+]i transients in rat or mouse cardiac myocytes. These effects were significantly attenuated by blockade of either extracellular signal regulated kinase 1/2 (ERK1/2) with PD98059 or Src with herbimycin A, suggesting a role of ERK1/2 and Src kinases in the positive inotropic effect of DRRSAb. More importantly, DRRSAb significantly increased cell survival rates for at least 24 h after isolating from the heart. Activation of NKA also protected hearts against ischaemic injury in both cardiomyocytes and isolated hearts. The protective effect was reversed by blockade of ERK1/2 or phosphoinositide 3-kinase (PI3K)/Akt but not by inhibition of protein kinase C. The involvement of ERK1/2 and PI3K/Akt was further confirmed by examining the phosphorylation of these kinases with western blot analysis. Activation of NKA with DRRSAb induces both positive inotropic and cardioprotective effects via stimulation of Src/PI3K/Akt/ERK1/2 pathways. The unique properties of DRRSAb may make NKA antibody a promising drug to treat heart failure.Keywords
This publication has 37 references indexed in Scilit:
- Activation of (Na++K+)-ATPase Modulates Cardiac L-Type Ca2+ Channel FunctionMolecular Pharmacology, 2009
- Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signalingOncogene, 2007
- Differential regulation and properties of MAPKsOncogene, 2007
- Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat heartsCardiovascular Research, 2007
- Activation of (Na++K+)-ATPase induces positive inotropy in intact mouse heart in vivoBiochemical and Biophysical Research Communications, 2006
- Survival kinases in ischemic preconditioning and postconditioningCardiovascular Research, 2006
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Involvement of Src and Epidermal Growth Factor Receptor in the Signal-transducing Function of Na+/K+-ATPaseJournal of Biological Chemistry, 2000
- Hypoxia, Metabolic Inhibition, and Isolated Rat Mesenteric Tone: Influence of Arterial DiameterMicrovascular Research, 2000
- Protein Kinase C Inhibitors Abolish the Increased Resistance of Diabetic Rat Heart to Ischemia-Reperfusion Injury.The Japanese Journal of Physiology, 1999